Why Execution Excellence Now Defines Biopharma Winners

In today’s biopharma environment, strategy and science alone aren’t enough. Harry Georgiades, Managing Director at IPM, shares why execution excellence is now the true differentiator—and how leading organizations turn strategy into action across the product lifecycle. As teams move faster while maintaining quality and compliance, success depends on aligning process, governance, and execution. When done right, speed and compliance go hand in hand. Looking ahead, adaptability is key. The organizations that win will be those investing in operating models that connect people, process, and technology to drive results and respond to change.